Patient access where medical groups excel drives higher commercial patient retention and boosts operational performance, Kaufman Hall reports.

Novo Nordisk remains a dominant business with a strong pipeline, and current multiples are low enough to justify a buy. Read my latest analysis of NVO stock.

Learn why Excel’s Advanced Filter sometimes returns partial matches — and how to control or fix it for precise data filtering ...